Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02792192
Title Safety and Pharmacology Study of Atezolizumab Alone and in Combination With Bacille Calmette-Guérin (BCG) in High-risk Non-muscle-invasive Bladder Cancer (NMIBC) Participants
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Stanford Univ. Stanford California 94305 United States Details
University of Chicago Medical Center Chicago Illinois 60637 United States Details
Johns Hopkins Kimmel Cancer Center, Office of Research Administration Baltimore Maryland 21205 United States Details
The Montefiore Medical Center & The Albert Einstein College of Medicine; Department of Urology Bronx New York 10461 United States Details
Duke University Durham North Carolina 27705 United States Details
Ohio State University Columbus Ohio 43210 United States Details
Oklahoma University Health Sciences Center Oklahoma City Oklahoma 73104 United States Details
VA Portland Healthcare System Portland Oregon 97239 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field